Clinical Biosafety Services, a subsidiary of Sabai Global
Biotechnology ResearchView the employees at
Clinical Biosafety Services, a subsidiary of Sabai Global-
Jessica Poole Associate Partner and Gene Therapy Biosafety Officer
-
Port St Lucie, Florida, United States
-
Top 5%
Hallie H. Facilitating Advances through Human Gene Therapy-
Eugene, Oregon, United States
-
Top 5%
Patrick Conley Director of IBC Operations at Clinical Biosafety Services-
Dallas, Texas, United States
-
Rising Star
Jennifer N. Smith Associate Partner and Gene Therapy Biosafety Officer at Clinical Biosafety Services-
Kansas City Metropolitan Area
-
Top 10%
Marian Hemmelgarn Associate Partner and Gene Therapy Biosafety Officer at Clinical Biosafety Services-
Morrisville, North Carolina, United States
-
Top 10%
Overview
Gene Therapy. Accelerated. Clinical Biosafety Services provides Institutional Biosafety Committee (IBC) Review and Biosafety Consulting Services. Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor. Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.
-